CLINICAL_TRIALS
trial_result
· 2014-03-03
Clinical Trial Update: Exploratory Study of OPC-12759 Ophthalmic Suspension [Phase 2]
Summary
This document reports Phase 2 exploratory results for OPC-12759 ophthalmic suspension in keratoconjunctival epithelial disorder. The sponsor is Otsuka Pharmaceu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Keratoconjunctival Epithelial Disorder | Phase 2 | Status: COMPLETED | Results posted: 2014-03-03